273 related articles for article (PubMed ID: 23732716)
1. Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening.
Etzioni R; Gulati R; Mallinger L; Mandelblatt J
Ann Intern Med; 2013 Jun; 158(11):831-8. PubMed ID: 23732716
[TBL] [Abstract][Full Text] [Related]
2. A reality check for overdiagnosis estimates associated with breast cancer screening.
Etzioni R; Xia J; Hubbard R; Weiss NS; Gulati R
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25362701
[TBL] [Abstract][Full Text] [Related]
3. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.
Draisma G; Etzioni R; Tsodikov A; Mariotto A; Wever E; Gulati R; Feuer E; de Koning H
J Natl Cancer Inst; 2009 Mar; 101(6):374-83. PubMed ID: 19276453
[TBL] [Abstract][Full Text] [Related]
4. The benefits and harms of breast cancer screening: an independent review.
Independent UK Panel on Breast Cancer Screening
Lancet; 2012 Nov; 380(9855):1778-86. PubMed ID: 23117178
[TBL] [Abstract][Full Text] [Related]
5. Breast, prostate, and thyroid cancer screening tests and overdiagnosis.
Jung M
Curr Probl Cancer; 2017; 41(1):71-79. PubMed ID: 28104314
[TBL] [Abstract][Full Text] [Related]
6. Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme.
Michalopoulos D; Duffy SW
J Med Screen; 2016 Dec; 23(4):192-202. PubMed ID: 26940963
[TBL] [Abstract][Full Text] [Related]
7. Missteps in Current Estimates of Cancer Overdiagnosis.
Lee CI; Etzioni R
Acad Radiol; 2017 Feb; 24(2):226-229. PubMed ID: 27894707
[TBL] [Abstract][Full Text] [Related]
8. Recognizing the Limitations of Cancer Overdiagnosis Studies: A First Step Towards Overcoming Them.
Etzioni R; Gulati R
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26582245
[TBL] [Abstract][Full Text] [Related]
9. Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis.
Zahl PH; Jørgensen KJ; Gøtzsche PC
Br J Cancer; 2013 Oct; 109(7):2014-9. PubMed ID: 23963144
[TBL] [Abstract][Full Text] [Related]
10. Overdiagnosis and overtreatment of prostate cancer.
Loeb S; Bjurlin MA; Nicholson J; Tammela TL; Penson DF; Carter HB; Carroll P; Etzioni R
Eur Urol; 2014 Jun; 65(6):1046-55. PubMed ID: 24439788
[TBL] [Abstract][Full Text] [Related]
11. Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population Studies.
Gulati R; Feuer EJ; Etzioni R
Am J Epidemiol; 2016 Jul; 184(2):140-7. PubMed ID: 27358266
[TBL] [Abstract][Full Text] [Related]
12. Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach.
Pathirana T; Hayen A; Doust J; Glasziou P; Bell K
BMJ Open; 2019 Mar; 9(3):e022457. PubMed ID: 30858156
[TBL] [Abstract][Full Text] [Related]
13. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
Coldman A; Phillips N
CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
[TBL] [Abstract][Full Text] [Related]
15. Extrapolation of pre-screening trends: Impact of assumptions on overdiagnosis estimates by mammographic screening.
Ripping TM; Verbeek AL; Ten Haaf K; van Ravesteyn NT; Broeders MJ
Cancer Epidemiol; 2016 Jun; 42():147-53. PubMed ID: 27153471
[TBL] [Abstract][Full Text] [Related]
16. Overdiagnosis in cancer.
Welch HG; Black WC
J Natl Cancer Inst; 2010 May; 102(9):605-13. PubMed ID: 20413742
[TBL] [Abstract][Full Text] [Related]
17. [Discrepancies and overdiagnosis in breast cancer organized screening. A "methodology" systematic review].
Gocko X; Leclerq M; Plotton C
Rev Epidemiol Sante Publique; 2018 Nov; 66(6):395-403. PubMed ID: 30316554
[TBL] [Abstract][Full Text] [Related]
18. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.
Duffy SW; Agbaje O; Tabar L; Vitak B; Bjurstam N; Björneld L; Myles JP; Warwick J
Breast Cancer Res; 2005; 7(6):258-65. PubMed ID: 16457701
[TBL] [Abstract][Full Text] [Related]
19. Quantification of overdiagnosis in randomised trials of cancer screening: an overview and re-analysis of systematic reviews.
Voss T; Krag M; Martiny F; Heleno B; Jørgensen KJ; Brandt Brodersen J
Cancer Epidemiol; 2023 Jun; 84():102352. PubMed ID: 36963292
[TBL] [Abstract][Full Text] [Related]
20. Overdiagnosis in breast cancer screening: The impact of study design and calculations.
Lynge E; Beau AB; Christiansen P; von Euler-Chelpin M; Kroman N; Njor S; Vejborg I
Eur J Cancer; 2017 Jul; 80():26-29. PubMed ID: 28535494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
